Qingfeng Ma
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Epidemiology 10
- Acute Ischemic Stroke Management 6
- Hepatitis B Virus Studies 3
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Cancer-related gene regulation 2
- Co-authors
- Wei Wang (5 shared papers)Chengliang Zhu (5 shared papers)Huan Han (2 shared papers)Fang Liu (2 shared papers)Xinghui Liu (4 shared papers)Cong Li (1 shared paper)Rui Liu (1 shared paper)Pingan Zhang (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (1 paper)European Stroke Journal (1 paper)Pharmaceuticals (1 paper)Current Neurovascular Research (1 paper)Journal of Clinical Laboratory Analysis (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Qingfeng Ma
17 papers receiving 1.0k citations
Qingfeng Ma's Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 535
- Neurology 297
- Biological Psychiatry 13
- Critical Care and Intensive Care Medicine 22
- Immunology 102
Countries citing papers authored by Qingfeng Ma
This map shows the geographic impact of Qingfeng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Ma more than expected).
Fields of papers citing papers by Qingfeng Ma
This network shows the impact of papers produced by Qingfeng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Ma. The network helps show where Qingfeng Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingfeng Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors Hit paper breakdown → | 2020 | 850 |
| 2 | 2020 | 70 | |
| 3 | 2024 | 34 | |
| 4 | 2020 | 22 | |
| 5 | 2018 | 17 | |
| 6 | 2019 | 17 | |
| 7 | 2017 | 11 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 8 | |
| 10 | 2020 | 6 | |
| 11 | 2019 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2025 | 0 | |
| 19 | Effect of xuezhikang on serum inflammatory cytokines in patients with unstable angina pectoris. | 2008 | 0 |
| 20 | 2025 | 0 |
About Qingfeng Ma
Qingfeng Ma is a scholar working on Epidemiology, Molecular Biology, Neurology, Infectious Diseases and Complementary and alternative medicine, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (6 papers), RNA modifications and cancer (4 papers), Hepatitis B Virus Studies (3 papers), RNA Research and Splicing (3 papers), Cancer-related gene regulation (2 papers), COVID-19 Clinical Research Studies (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (535 citations), Neurology (297 citations), Biological Psychiatry (13 citations), Critical Care and Intensive Care Medicine (22 citations) and Immunology (102 citations). Qingfeng Ma has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Wei Wang, Chengliang Zhu, Huan Han, Fang Liu, Xinghui Liu, Cong Li, Rui Liu, Pingan Zhang, Yuchen Xia and Xiaoming Cheng. Their work appears in journals such as Biochemical and Biophysical Research Communications, European Stroke Journal, Pharmaceuticals, Current Neurovascular Research and Journal of Clinical Laboratory Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.